Gilead Sciences, Inc. (GILD) Put Players Make Rare Appearance

Gilead Sciences, Inc. (NASDAQ:GILD) is one more victim of Hillary Clinton's price-gouging tweet

Sep 21, 2015 at 3:17 PM
facebook twitter linkedin


Gilead Sciences, Inc. (NASDAQ:GILD) is yet another biotech stock hurting today, due to presidential nominee Hillary Clinton's anti-price-gouging tweet. Although this comes directly on the heels of positive late-stage trial data for GILD's hepatitis C treatment, the shares were last seen 2.8% lower at $105.46 -- which has led to a fresh round of bearish option trading. 

By the numbers, GILD puts are changing hands at a pace 1.6 times the intraday average. Traders have taken a particular interest in the 107 strike, and appear to be buying to open the weekly 9/25 and October puts. If traders are indeed purchasing new positions, they are betting on extended losses from the drugmaker through this Friday's close, and the close on Friday, Oct. 16 -- the contracts' respective expiration dates. 

This preference for puts over calls is a sudden change for GILD speculators. During the past two weeks at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the security has amassed a call/put volume ratio of 3.07. Not only does this mean more three calls have been bought to open for each put, but it also ranks higher than 86% of all other readings from the past year. This signals a stronger-than-usual appetite for calls over puts. 

Elsewhere on the Street, analysts have taken a decidedly bullish tone. Sixteen brokerage firms cover GILD, 13 of which say the shares are a "buy" or better. Moreover, the equity's average 12-month price target of $125.06 represents a 19% premium to current levels, and territory never before charted. 

Regardless, Gilead Sciences, Inc. (NASDAQ:GILD) has been a steady climber on the charts. Even with today's losses, the stock is 12% higher year-to-date. 
 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

 


 


 
Special Offers from Schaeffer's Trading Partners